Skip to main content
CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Alivus Life Sciences Ltd.

NSE : ALIVUSEQ BSE : 543322 ISIN CODE : INE03Q201024Industry : Pharmaceuticals

News

  • Alivus Life Sciences - General Updates 11 Nov 2026 | 18:31 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about update on acquisitionmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Updates on Acquisition 11 Nov 2026 | 18:29 | Dion Global

    Enclosed please find herewith update on acquisition.more...

  • Alivus Life Sciences - General Updates 11 Nov 2026 | 17:00 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (LODR) 2015more...

  • Alivus Life Sciences - Announcement Under Regulation 30 - Updates 11 Nov 2026 | 16:53 | Dion Global

    Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR) 2015.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 06 Nov 2026 | 15:26 | Dion Global

    Please find attached herewith submission with respect to transcript of the earning call.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 06 Nov 2026 | 15:22 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Transcriptmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 03 Nov 2026 | 19:42 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 03 Nov 2026 | 19:40 | Dion Global

    Please find enclosed herewith intimation for Analyst/Investor meeting.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 30 Oct 2026 | 17:56 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meet.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 30 Oct 2026 | 17:54 | Dion Global

    Please find enclosed herewith intimation for Analyst/Investor Meet.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Oct 2026 | 15:21 | Dion Global

    We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30 2026 on the website of the Company.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 30 Oct 2026 | 15:20 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Link of Recording of Earning Call.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 29 Oct 2026 | 19:58 | Dion Global

    Please find enclosed herewith intimation with respect to allotment of equity shares under \Employee Stock Option Scheme 2021\more...

  • Alivus Life Sciences - ESOP/ESOS/ESPS 29 Oct 2026 | 19:56 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding Exercise of 195833 Options.more...

  • Alivus Life Sciences - Investor Presentation 29 Oct 2026 | 19:36 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation 29 Oct 2026 | 19:36 | Dion Global

    Please find enclosed herewith Investor Presentation for Q2 FY26-27.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release 29 Oct 2026 | 19:34 | Dion Global

    Please find enclosed Press Release of the Company for the Second Quarter and Half Year ended September 30 2026.more...

  • Alivus Life Sciences - Press Release 29 Oct 2026 | 19:33 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding a press release dated October 29 2026 titled Press Release of the Company f...more...

  • Alivus Life Sciences Q2 net profit jumps 51.31% at Rs 196.75 cr 29 Oct 2026 | 19:30 | Dion Global

    The company reported standalone net profit of Rs 196.75 crore for the quarter ended September 30 2026 as compared to Rs 130.03 crore in the same peri...more...

  • Alivus Life Sciences - Board Meeting Outcome for Unaudited Financial Results For The Second Quarter And Half Year Ended Septe 29 Oct 2026 | 19:29 | Dion Global

    Please find enclosed Unaudited Financial Results for the Second quarter and Half Year ended September 30 2026.more...


Global Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
DOW Jones45473.55Up0.16%
Nasdaq21794.16Up0.43%
S&P 5006496.04Up0.22%
Nikkei 22543643.81Up1.45%
Hang Seng25633.91Up0.85%
Shanghai Composite3826.84Up0.38%

Indian Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
Sensex82104.79Up0.63%
NSE Index25291.1Up0.58%
B500DIVL503481.93Down-0.20%
BSE 1000 11105.65Down-0.07%
BSE 100LCTMC9457.59Up0.37%
BSE Auto 60641.87Down-1.29%

Commodity


Commodity prices table showing commodity names, current prices, and percentage changes
Commodity Name Current Price Direction Change (%)
Gold134176Down-1.19%
Silver169914Down-4.32%
Copper1329.7Up226.07%
Crude Oil8342Up30.08%
Lead196.85Up46.47%
Mentha Oil1448.1Up35.67%
Nickel1531.2Up99.66%

Currency


Currency exchange rates table showing currency pairs, exchange rates, and percentage changes
Currency Pair Exchange Rate Direction
USD/INR94.2000 (0.46%)Up
GBP/INR124.6100 (0.26%)Up
EUR/INR104.1800 (0.32%)Up
JPY/INR0.5900 (0.57%)Up
CAD/INR65.7400 (0.00%)Up
HKD/INR11.9500 (-0.02%)Down